De A. Lourenco

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Tracking Health Related Quality of Life From Diagnosis to Follow-Up Among Australian Children With Acute Lymphoblastic Leukaemia.

Tracking Health Related Quality of Life From Diagnosis to Follow-Up Among Australian Children With Acute Lymphoblastic Leukaemia.

Journal: Pediatric blood & cancer

Published: December 18, 2025

Oncologist and General Practitioner Perspectives of Telehealth-Delivered Colorectal Cancer Survivorship Care.

Oncologist and General Practitioner Perspectives of Telehealth-Delivered Colorectal Cancer Survivorship Care.

Journal: Psycho-oncology

Published: December 17, 2025

Maximising Participation in the Australian National Lung Cancer Screening Program: A Discrete Choice Experiment of Eligible, High-Risk Individuals.

Maximising Participation in the Australian National Lung Cancer Screening Program: A Discrete Choice Experiment of Eligible, High-Risk Individuals.

Journal: Respirology (Carlton, Vic.)

Published: August 08, 2025

Feasibility evaluation of a virtual lifestyle intervention for early-stage breast cancer survivors undergoing chemotherapy.

Feasibility evaluation of a virtual lifestyle intervention for early-stage breast cancer survivors undergoing chemotherapy.

Journal: JNCI cancer spectrum

Published: July 22, 2025

'Making Moves': Protocol for a hybrid effectiveness-implementation pre-post trial of a co-designed online physical activity program for childhood cancer survivors.

'Making Moves': Protocol for a hybrid effectiveness-implementation pre-post trial of a co-designed online physical activity program for childhood cancer survivors.

Journal: JSAMS plus

Published: March 18, 2025

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 10, 2024

Cross-Cultural Validation of the COmprehensive Score for Financial Toxicity (COST) Measure in an Australian Sample.

Cross-Cultural Validation of the COmprehensive Score for Financial Toxicity (COST) Measure in an Australian Sample.

Journal: Cancer medicine

Published: August 25, 2024

Using patient-reported outcome measures in clinical trials: perspectives for and against a modular approach.

Using patient-reported outcome measures in clinical trials: perspectives for and against a modular approach.

Journal: The Medical journal of Australia

Published: July 10, 2024

Sugar-sweetened beverage consumption in Thailand: Determinants and variation across socioeconomic status.

Sugar-sweetened beverage consumption in Thailand: Determinants and variation across socioeconomic status.

Journal: Public health

Published: May 26, 2024

Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review.

Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review.

Journal: Transplantation and cellular therapy

Published: October 16, 2023

The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.

The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.

Journal: BJU international

Published: August 21, 2023

Discrete Event Simulation to Incorporate Infusion Wait-Time When Assessing Cost-Effectiveness of a Chimeric-Antigen Receptor T Cell Therapy.

Discrete Event Simulation to Incorporate Infusion Wait-Time When Assessing Cost-Effectiveness of a Chimeric-Antigen Receptor T Cell Therapy.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: June 28, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026